Topical Immunotherapy for Alopecia areata: Re-Evaluation of 139 Cases after an Additional Follow-Up Period of 19 Months

Dermatology ◽  
1992 ◽  
Vol 184 (3) ◽  
pp. 198-201 ◽  
Author(s):  
P.H.M. van der Steen ◽  
J.B.M. Boezeman ◽  
R. Happle
Keyword(s):  
Alopecia Areata ◽  
Topical Immunotherapy

scholarly journals A reasonable Response to Diphensiprone in Pediatric Alopecia Patient: A Case Report

2021 ◽  
Vol 2 (1) ◽  
pp. 01-03
Author(s):  
Selma Bakar DERTLİOĞLU
Keyword(s):  
Quality Of Life ◽  
Alopecia Areata ◽  
Autoimmune Disorder ◽  
Age Group ◽  
Pediatric Age ◽  
Pediatric Age Group ◽  
Topical Immunotherapy ◽  
Treatment Alternatives

Alopecia areata (AA) is an autoimmune disorder which accounts for the most frequent cause of inflammation based hair loss among dermatological outpatient attendances. It has an unpredictable course and its etiology has not yet been fully elucidated. Many alternatives treatments are available; however, none of them have been curative or preventive so far. Its treatment must be individualized, and aims at suppressing the phase of activity of the disease. Alopecia areata (AA) persistent for a minimum of 6 months and resistant to other treatments and/or severe AA are indications to use diphencyprone (DPCP). We report a 9 year-old boy with diffuse alopecia areata, who underwent topical immunotherapy with diphencyprone. The application procedures, the results obtained and the clinical follow-up are described. Treatment alternatives should be tried, especially in the pediatric age group, due to the prominent effects of the disease on the patient’s quality of life and consequent development of psychological impairments. In this case; DPCP application is a preferable treatment option in AA in the pediatric age group because is very easy, effective and with less side effects

Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study

2015 ◽  
Vol 28 (5) ◽  
pp. 309-317 ◽  
Author(s):  
Jovan Lalosevic ◽  
Mirjana Gajic-Veljic ◽  
Branka Bonaci-Nikolic ◽  
Milos Nikolic
Keyword(s):  
Topical Corticosteroid ◽  
Corticosteroid Therapy ◽  
Alopecia Areata ◽  
Follow Up Study ◽  
Long Term Follow Up

scholarly journals Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients

2020 ◽  
Vol 69 (2) ◽  
pp. 274-278
Author(s):  
Keisuke Sakai ◽  
Satoshi Fukushima ◽  
Satoru Mizuhashi ◽  
Masatoshi Jinnin ◽  
Takamitsu Makino ◽  
...  
Keyword(s):  
Alopecia Areata ◽  
Japanese Patients ◽  
Squaric Acid ◽  
Topical Immunotherapy

Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Maryam Nasimi ◽  
Robabeh Abedini ◽  
Narges Ghandi ◽  
Hassan Seirafi ◽  
Mahdieh Sadat Mehdizade ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Alopecia Areata ◽  
Topical Immunotherapy ◽  
Large Retrospective Study

scholarly journals Dapsone versus topical immunotherapy in alopecia areata

1995 ◽  
Vol 133 (2) ◽  
pp. 270-274 ◽  
Author(s):  
H.M.J. BAAR ◽  
C.J.M. VLEUTEN ◽  
P.C.M. KERKHOF
Keyword(s):  
Alopecia Areata ◽  
Topical Immunotherapy

Topical immunotherapy with diphencyprone in the treatment of extensive and/or long-lasting alopecia areata

2005 ◽  
Vol 19 (3) ◽  
pp. 393-394 ◽  
Author(s):  
A Firooz ◽  
N Bouzari ◽  
F Mojtahed ◽  
H Pazoki-Toroudi ◽  
M Nassiri-Kashani ◽  
...  
Keyword(s):  
Alopecia Areata ◽  
Topical Immunotherapy

Alopecia areata: A long term follow-up study of 191 patients

2006 ◽  
Vol 55 (3) ◽  
pp. 438-441 ◽  
Author(s):  
Antonella Tosti ◽  
Sara Bellavista ◽  
Matilde Iorizzo
Keyword(s):  
Alopecia Areata ◽  
Follow Up Study ◽  
Long Term Follow Up

scholarly journals Topical immunotherapy in alopecia areata

2010 ◽  
Vol 2 (1) ◽  
pp. 36 ◽  
Author(s):  
Gurcharan Singh ◽  
MS Lavanya
Keyword(s):  
Alopecia Areata ◽  
Topical Immunotherapy
Sign in / Sign up

Export Citation Format

Share Document